Please login to the form below

Not currently logged in
Email:
Password:

Roche's anti-obesity drug Xenical faces generic competition in UK

Teva launches first generic version of orlistat

Roche's anti-obesity brand Xenical (orlistat) is facing generic competition in the UK after Teva launched its version of the drug.

The company will sell its prescription-only version of Xenical at £27.60 for 120mg capsule x 84, under-cutting the £31.63 list price of Roche's branded version.

Kim Innes, commercial director at Teva, said: "We're delighted to be the first company to launch generic orlistat in the UK.

"As the UK's leading supplier of generics, we're pleased not only to have the widest portfolio of our competitors, but also to show that we're well-placed when it comes to innovation and being the first to market."

Xenical is indicated to treat obese patients with a body mass index (BMI) greater or equal to 30kg/m2, or overweight patients (BMI greater than or equal to 28kg/m2) with associated risk factors, in conjunction with a mildly hypocaloric diet.

The drug is also marketed in a reduced strength, non-prescription form by GlaxoSmithKline (GSK) as Alli, but the company is planning to divest it and other non-key OTC brands.

12th December 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Top 10 ways that Medical Affairs teams can leverage the Impetus InSite Platform®
Some of the most popular and innovative ways of using our cutting-edge asynchronous and synchronous virtual tools for Medical Affairs teams....
The power of communication: Engaging diverse groups in healthcare
Humans are diverse and communications to engage us need to be inclusive. It’s no longer about talking to a group, a cohort or an imagined section of society - especially...
Building the hospital of the future
Senior Consultant Leah Carlisle explores the growing trend of virtual hospitals and what it takes to develop a holistic digital ecosystem centered on the ultimate patient experience....